Skip to contentI
iBio, Inc.
I
IBIOiBio, Inc. Q3 2016 · 10-Q
Revenue$379.00K$379.00K+8.6% vs Q3 2015 Net Income-$3.04M-$3.04MN/M vs Q3 2015 EPS Diluted-$0.04-$0.04N/M vs Q3 2015 Operating Income-$3,072,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$2,439,000N/M Margins · derivedOperating margin-810.6%−326.9 pt vs Q3 2015
Net margin-801.1%−320.5 pt vs Q3 2015
ended Mar 31, 2016 · filed May 23, 2016 · 53 d after period end